4.7 Review

Pancreatic Cancer and Platelets Crosstalk: A Potential Biomarker and Target

期刊

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2021.749689

关键词

pancreatic cancer; platelets; TCIPA; platelet-derived factors; platelet extracellular vesicles; angiogenesis; organoids; biomarker

资金

  1. European Unions Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant [86119]
  2. Medical Univeristy of Gdansk [St-54]

向作者/读者索取更多资源

Platelets have been identified as crucial players in hemostasis, thrombosis, and cancer progression. Research has shown that platelets can promote tumorigenesis and metastasis by interacting with cancer cells in various ways. Understanding the interaction between pancreatic cancer and platelets, as well as the underlying mechanisms, may offer insights into potential diagnostic and therapeutic strategies for combating the devastating disease.
Platelets have been recognized as key players in hemostasis, thrombosis, and cancer. Preclinical and clinical researches evidenced that tumorigenesis and metastasis can be promoted by platelets through a wide variety of crosstalk between cancer cells and platelets. Pancreatic cancer is a devastating disease with high morbidity and mortality worldwide. Although the relationship between pancreatic cancer and platelets in clinical diagnosis is described, the interplay between pancreatic cancer and platelets, the underlying pathological mechanism and pathways remain a matter of intensive study. This review summaries recent researches in connections between platelets and pancreatic cancer. The existing data showed different underlying mechanisms were involved in their complex crosstalk. Typically, pancreatic tumor accelerates platelet aggregation which forms thrombosis. Furthermore, extracellular vesicles released by platelets promote communication in a neoplastic microenvironment and illustrate how these interactions drive disease progression. We also discuss the advantages of novel model organoids in pancreatic cancer research. A more in-depth understanding of tumor and platelets crosstalk which is based on organoids and translational therapies may provide potential diagnostic and therapeutic strategies for pancreatic cancer progression.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据